Yariana E. Rodríguez Ortiz

Nephrologist in Houston, Past CIR-SEIU National Vice-President 2022-2024 Public policy, Advocacy, General Nephrology, Health Disparities. Tweets are my own view

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) ca. 2026 from @goKDIGO
#Nephpearls

👉 https://t.co/umbJh2Jfzd

[Yariana E. Rodríguez Ortiz @yari_nephro]

The Houston Methodist Nephrology Program has two openings for its Nephrology Fellowship!
Take the next step in your career by training at one of the top hospitals in the nation. Interested? Email Deanna Congdon at [email protected]

[Yariana E. Rodríguez Ortiz @yari_nephro]

Had the privilege to hear Dr. Bobart give this amazing talk! Feels like yesterday when we wrote an IgA blog piece and rounded together. #asn #kidneyweek #gn

[Yariana E. Rodríguez Ortiz @yari_nephro]

Ready for kidney week! For more women in nephrology ❤️🥼 #asn #kidneyweek

[Yariana E. Rodríguez Ortiz @yari_nephro]

Proud to be part of the 6-7% of Hispanic Physicians in the Nation. National Latino Physician Day 🇵🇷🥼 https://t.co/T2kpxAvGe9

[KDIGO @goKDIGO]

KDIGO is excited to share the publication of the 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV), along with the Executive Summary in @Kidney_Int.

Read the Guideline in KI: https://t.co/OvxwTGjjXx

Download the Executive Summary: https://t.co/WLJLwFnlZq

Read the News Release: https://t.co/gHZ1yvcuoe

Co-chaired by Dr. Jürgen Floege (DE) and @BradRovin, this update to the 2021 KDIGO Glomerular Diseases Guideline on IgAN incorporates evidence through August 2024. Given the rapid pace of discovery, KDIGO will continue to update the guideline regularly so clinicians and patients have access to the latest science and recommendations.

“This guideline represents a fundamental shift in how we approach IgA nephropathy,” said Dr. Floege. “For the first time, we can target both the immune mechanisms driving IgA injury and the kidney’s maladaptive responses. This dual strategy offers a roadmap to slow progression and extend kidney survival in ways not possible just a few years ago.”

“The science is moving faster than ever, and the treatment landscape has changed dramatically,” said Dr. Rovin. “With therapies like targeted-release budesonide, sparsentan, and SGLT2 inhibitors, we can intervene earlier and tailor care. We are moving from a single approach to a toolkit of therapies that can truly change outcomes for people around the world."

Download the Guideline: https://t.co/NUzPHXN4Zu

[Shane Bobart, MD, FASN @ShaneBobart]

Check out our editorial in @AJKDonline @DrTariqShafi

[Yariana E. Rodríguez Ortiz @yari_nephro]

Happy National Doctors Day! So thankful to have crossed path with many physicians that have been part of my journey. I reflect on how important a good support system is to thrive in this profession. May I always wear my white coat with humbleness and pride. #NationalDoctorsDay 🇵🇷

[Yariana E. Rodríguez Ortiz @yari_nephro]

#1 ❤️

[AJKD @AJKDonline]

Counting down the Top Ten #AJKDBlog posts of 2024... Drumroll, please!

1️⃣ Commentary by @yari_nephro and @shanebobart:

IgA Nephropathy, The Hope of Tomorrow, Is Here

https://t.co/hxj6k6Sv5o (FREE)

@Khairallah_P

[Yariana E. Rodríguez Ortiz @yari_nephro]

#doximity

Digital Health Fellow 2024🥼🥼

https://t.co/fPVMHFwQUX

[Yariana E. Rodríguez Ortiz @yari_nephro]

Patients should feel safe and be able to get access to care with no fear. Although it is optional to answer, this likely will be a barrier to healthcare access for ilegal immigrants in Texas. Let’s see what the future holds…#healthcareaccess #advocacy https://t.co/8vgQwb9lrG

[ASN Publications @asnpublications]

Cause-specific mortality data from the USRDS form the basis for identifying CVD, specifically SCD, as the leading cause of death for patients on dialysis. This study found that significant discordance exists in the causes of death for patients on dialysis reported by the USRDS and the NDI. https://t.co/U0EilIHWn5
@DanTheKidneyMan
@DrTariqShafi
@Yoshi_Obi

[Yariana E. Rodríguez Ortiz @yari_nephro]

@SamirNangia @DallasRenal @TCUBurnettMed @TCUMagazine @mhshospitals @methodistdallas @methodistmans Well deserved! Congrats!!

[Yariana E. Rodríguez Ortiz @yari_nephro]

@stephanietr612 I love it!!!!🇵🇷🇵🇷🥼

[Yariana E. Rodríguez Ortiz @yari_nephro]

Happy National Latino Physician Day! Because 6% is not enough. 🥼🥼🥼❤️🥼🥼 Proud to be a female Puertorrican Physician! #NationalLatinoPhysicianDay

[Tiffany Caza @Tiff_Caza]

A new diabetic nephropathy classification including tubulointerstitial and vascular lesions may have good predictive value.
@GlomCon

[Yariana E. Rodríguez Ortiz @yari_nephro]

Let us remember to check on our colleagues, but also to be kind to ourselves. Many physicians struggle with mental health issues, and sadly not enough policies have been implemented to aid in this. Take a minute of silence today to reflect on those who sadly are not with us today

[Stephanie Torres M.D. @stephanietr612]

🌟 Top 1️⃣0️⃣ takeaways for the management of ANCA Associated Vasculitis (AAV) 🌟

#GlomConHawaii

[Yariana E. Rodríguez Ortiz @yari_nephro]

Excited that @GlomCon is discussing health literacy and patient education for our GN patients. As a new attending, and a fellow who did her grand rounds on patient education, I can attest to the importance of this. If patients understand their disease, compliance improves#nephro

[Yariana E. Rodríguez Ortiz @yari_nephro]

Reflecting as a new attending…Why can’t the @AmerMedicalAssn advocate for one central credentialing system for physicians? That way new attending physicians can start working early, and practices decrease their fees on credentialing new physicians with multiple privileges sites.